Author: Cadernos De Saúde Pública

Challenges of the COVID-19 pandemic: for a Brazilian research agenda in global health and sustainability [Originally published in Cad. Saúde Pública, vol.36 no.4]

This article aims to reflect on the new boom in research output in the field of global health, based on two analytical elements that we consider essential. The first is the important shift in the Brazilian State’s role in international relations, including a significant loss of leadership in the implementation of the Sustainable Development Goals (SDG) under the 2030 Agenda. The second is sustainability, with a fundamental focus on a research agenda in the field of global health. Read More →

Science during the pandemic [Originally published in Cad. Saúde Pública, vol.36 no.4]

Various scientific journals in Brazil have published studies on the impact of primary healthcare (PHC) on the population’s health, including in identifying the limits and conditions for improvement in the current context. However, rather than improving the PHC proposal, there have been mass layoffs. Scientists have also decried the underfinancing of SUS, including the impacts of a fiscal austerity policy that has cut essential budget funding from the social and health areas. Read More →

Food (in)security in Brazil in the context of the SARS-CoV-2 pandemic [Originally published in Cad. Saúde Pública, vol.36 no.4]

Although Brazil is experiencing the pandemic’s initial effects, the discussion on the country’s food security situation and its interfaces is of the utmost urgency, based on what has already happened in Europe. The food industry is facing numerous uncertainties, with limited orientation on food production, distribution, marketing, or home preparation of meals. Read More →

The novel coronavirus (SARS-CoV-2) emergency and the role of timely and effective national health surveillance [Originally published in Cad. Saúde Pública, vol.36 no.3]

In recent years, the emergence and reemergence of infectious diseases like bird flu (influenza A H5N1) in 2003, SARS in 2002/2003, influenza A (H1N1) in 2009, and Zika in 2015 raised numerous questions on the role of epidemiological surveillance. Pandemics have occurred more frequently, and since 2018, the World Health Organization (WHO) has acknowledged the need for preparation in anticipation of the emergence of novel pathogens, including (under the name “disease X”) unknown diseases with potential for international emergence on the priority list for research and development in the emergency setting. Read More →